- Home
- AGBK vs NVCT Comparison
AGBK vs NVCT Comparison
Compare AGBK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGBK | NVCT |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 823.2M | 672.1M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AGBK | NVCT |
|---|---|---|
| Price | $4.87 | $20.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $10.94 | ★ $35.40 |
| AVG Volume (30 Days) | ★ 612.3K | 164.7K |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $57.91 | N/A |
| Revenue Next Year | $35.02 | N/A |
| P/E Ratio | $46.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.43 | $5.77 |
| 52 Week High | $12.21 | $29.28 |
Technical Indicators
Market Signals| Indicator | AGBK | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 35.08 | 52.92 |
| Support Level | $4.43 | $19.78 |
| Resistance Level | $7.50 | $22.56 |
| Average True Range (ATR) | 0.52 | 1.59 |
| MACD | -0.16 | 0.10 |
| Stochastic Oscillator | 12.79 | 65.80 |
Price Performance
Historical ComparisonAbout AGBK AGI Inc Class A Common Shares
AGI Inc is a technology-powered provider of specialized financial services in Brazil. It empowers clients to access their social security benefits, severance fund benefits, and public or private sector payrolls through secured lending solutions and complementary banking, credit and insurance products tailored as per client needs. The company has one operating segment related to the banking business. The Bank provides a standardized set of financial products and services exclusively to individuals, mainly focused on credit, including digital accounts, cards, payroll and personal loans, and insurance offered through partners.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.